- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Synthetic 12 amino acids peptide designed after subcommissur
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Synthetic 12 amino acids peptide designed after subcommissural organ spondin
| EU orphan designation number: | EU/3/13/1206
|
| Active ingredient: | Synthetic 12 amino acids peptide designed after subcommissural organ spondin |
| Indication: | Treatment of spinal cord injury |
| Sponsor: | Neuronax SAS
Biopôle Clermont Limagne, 63360 Saint Beauzire, France |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 15/11/2013 | Orphan designation | EMA/OD/119/13 | (2013)8053 of 13/11/2013 |
CONTACT
EU links
Directorate General Health & Consumers